← Evidence map

ArticleFrontiers in pharmacology2025

ARID1A deficiency attenuates the response to EGFR-TKI treatment in lung adenocarcinoma.

Fangfang Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40463905